OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Selective degradation of BRD4 suppresses lung cancer cell proliferation using GSH-responsive PROTAC precursors
Heli Fan, Zhili Zhou, Dehao Yu, et al.
Bioorganic Chemistry (2023) Vol. 140, pp. 106793-106793
Closed Access | Times Cited: 15
Heli Fan, Zhili Zhou, Dehao Yu, et al.
Bioorganic Chemistry (2023) Vol. 140, pp. 106793-106793
Closed Access | Times Cited: 15
Showing 15 citing articles:
Restraining the power of Proteolysis Targeting Chimeras in the cage: A necessary and important refinement for therapeutic safety
Renshuai Zhang, Songbo Xie, Jie Ran, et al.
Journal of Cellular Physiology (2024) Vol. 239, Iss. 5
Closed Access | Times Cited: 10
Renshuai Zhang, Songbo Xie, Jie Ran, et al.
Journal of Cellular Physiology (2024) Vol. 239, Iss. 5
Closed Access | Times Cited: 10
Fine-tuning phenoxy silyl scaffolds for the development of glutathione-responsive prodrugs and antibody–drug conjugates
Wei Ding, Huihui Wang, Shangwei Huangfu, et al.
Bioorganic & Medicinal Chemistry (2025) Vol. 120, pp. 118088-118088
Closed Access
Wei Ding, Huihui Wang, Shangwei Huangfu, et al.
Bioorganic & Medicinal Chemistry (2025) Vol. 120, pp. 118088-118088
Closed Access
Targeting KRAS-G12C in Lung Cancer: The Emerging Role of PROTACs in Overcoming Resistance
Kumarappan Chidambaram, Arcot Rekha, Ahsas Goyal, et al.
Pathology - Research and Practice (2025), pp. 155954-155954
Closed Access
Kumarappan Chidambaram, Arcot Rekha, Ahsas Goyal, et al.
Pathology - Research and Practice (2025), pp. 155954-155954
Closed Access
Advances of E3 ligases in lung cancer
Jingwen Yu, Yiqi Zhao, Yue Xie
Biochemistry and Biophysics Reports (2024) Vol. 38, pp. 101740-101740
Open Access | Times Cited: 3
Jingwen Yu, Yiqi Zhao, Yue Xie
Biochemistry and Biophysics Reports (2024) Vol. 38, pp. 101740-101740
Open Access | Times Cited: 3
Conditional PROTAC: Recent Strategies for Modulating Targeted Protein Degradation
Junhyeong Yim, Jun‐Young Park, G. H. Kim, et al.
ChemMedChem (2024) Vol. 19, Iss. 22
Closed Access | Times Cited: 3
Junhyeong Yim, Jun‐Young Park, G. H. Kim, et al.
ChemMedChem (2024) Vol. 19, Iss. 22
Closed Access | Times Cited: 3
Controlled bioorthogonal activation of Bromodomain-containing protein 4 degrader by co-delivery of PROTAC and Pd-catalyst for tumor-specific therapy
Zhiyao Li, Tai‐Bai Jiang, Yuan Xu, et al.
Journal of Controlled Release (2024) Vol. 374, pp. 441-453
Closed Access | Times Cited: 2
Zhiyao Li, Tai‐Bai Jiang, Yuan Xu, et al.
Journal of Controlled Release (2024) Vol. 374, pp. 441-453
Closed Access | Times Cited: 2
Dual-responsive probe and DNA interstrand crosslink precursor target the unique redox status of cancer cells
Dehao Yu, Luo Wang, Jingao Li, et al.
Chemical Communications (2023) Vol. 59, Iss. 99, pp. 14705-14708
Closed Access | Times Cited: 5
Dehao Yu, Luo Wang, Jingao Li, et al.
Chemical Communications (2023) Vol. 59, Iss. 99, pp. 14705-14708
Closed Access | Times Cited: 5
Targeting BRD4 with PROTAC degrader ameliorates LPS-induced acute lung injury by inhibiting M1 alveolar macrophage polarization
Difei Li, Yao Deng, Guanxi Wen, et al.
International Immunopharmacology (2024) Vol. 132, pp. 111991-111991
Closed Access | Times Cited: 1
Difei Li, Yao Deng, Guanxi Wen, et al.
International Immunopharmacology (2024) Vol. 132, pp. 111991-111991
Closed Access | Times Cited: 1
Glutathione-dependent degradation of SMARCA2/4 for targeted lung cancer therapy with improved selectivity
Ming Ji, Dehao Yu, Xinmin Liu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 277, pp. 116751-116751
Closed Access | Times Cited: 1
Ming Ji, Dehao Yu, Xinmin Liu, et al.
European Journal of Medicinal Chemistry (2024) Vol. 277, pp. 116751-116751
Closed Access | Times Cited: 1
Redox‐Inducible Radiomimetic Photosensitizers Selectively Suppress Cancer Cell Proliferation by Damaging DNA through Radical Cation Chemistry
Heli Fan, Luo Wang, Xuanwei Zeng, et al.
Angewandte Chemie International Edition (2024) Vol. 64, Iss. 1
Closed Access | Times Cited: 1
Heli Fan, Luo Wang, Xuanwei Zeng, et al.
Angewandte Chemie International Edition (2024) Vol. 64, Iss. 1
Closed Access | Times Cited: 1
Glutathione-Dependent Degradation of Smarca2/4 for Targeted Lung Cancer Therapy with Improved Selectivity
Huabing Sun, Ming Ji, Dehao Yu, et al.
(2024)
Closed Access
Huabing Sun, Ming Ji, Dehao Yu, et al.
(2024)
Closed Access
Redox‐Inducible Radiomimetic Photosensitizers Selectively Suppress Cancer Cell Proliferation by Damaging DNA through Radical Cation Chemistry
Heli Fan, Luo Wang, Xuanwei Zeng, et al.
Angewandte Chemie (2024) Vol. 137, Iss. 1
Closed Access
Heli Fan, Luo Wang, Xuanwei Zeng, et al.
Angewandte Chemie (2024) Vol. 137, Iss. 1
Closed Access
Precision-engineered PROTACs minimize off-tissue effects in cancer therapy
Jianghua Shi, Luo Wang, Xuanwei Zeng, et al.
Frontiers in Molecular Biosciences (2024) Vol. 11
Open Access
Jianghua Shi, Luo Wang, Xuanwei Zeng, et al.
Frontiers in Molecular Biosciences (2024) Vol. 11
Open Access
Fine-Tuning Phenoxy Silyl Scaffolds for the Development of Glutathione-Responsive Prodrugs and Antibody−Drug Conjugates
Hongli Chen, Wei Ding, Huihui Wang, et al.
(2024)
Closed Access
Hongli Chen, Wei Ding, Huihui Wang, et al.
(2024)
Closed Access
Strategy and Design of In Situ Activated Protein Hydrolysis Targeted Chimeras
Mei-Yu Lv, Da‐Yong Hou, Shaowei Liu, et al.
ACS Nano (2024) Vol. 19, Iss. 1, pp. 101-119
Closed Access
Mei-Yu Lv, Da‐Yong Hou, Shaowei Liu, et al.
ACS Nano (2024) Vol. 19, Iss. 1, pp. 101-119
Closed Access
